Compare GRFS & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | GGAL |
|---|---|---|
| Founded | 1940 | 1905 |
| Country | Spain | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.2B |
| IPO Year | 2006 | N/A |
| Metric | GRFS | GGAL |
|---|---|---|
| Price | $8.92 | $51.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.30 | ★ $75.67 |
| AVG Volume (30 Days) | 667.0K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.60% | ★ 1.88% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.64 | 0.35 |
| Revenue | ★ $8,821,017,248.00 | $3,630,934,738.00 |
| Revenue This Year | $5.46 | $9.49 |
| Revenue Next Year | $5.60 | $13.17 |
| P/E Ratio | $17.34 | ★ $16.24 |
| Revenue Growth | ★ 7.31 | N/A |
| 52 Week Low | $6.19 | $25.89 |
| 52 Week High | $11.14 | $74.00 |
| Indicator | GRFS | GGAL |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 55.26 |
| Support Level | $7.64 | $50.95 |
| Resistance Level | $8.90 | $53.83 |
| Average True Range (ATR) | 0.27 | 2.54 |
| MACD | 0.07 | -0.47 |
| Stochastic Oscillator | 92.00 | 70.43 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.